Substance Use Comorbidity Care: Evidence-Based Stepped Strategies for Depression
药物使用合并症护理:基于证据的抑郁症阶梯策略
基本信息
- 批准号:7905074
- 负责人:
- 金额:$ 54.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-08-01 至 2013-07-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAbstinenceAddressAlcohol or Other Drugs useAlgorithmsBehavior TherapyBehavioralCaringClinicClinicalCognitiveCognitive TherapyCommunitiesComorbidityComplexDataDevelopmentDiseaseDisease remissionDropoutDrug usageFailureFrequenciesFutureGeneral PopulationGoalsHIVHealth StatusHuman ResourcesIllicit DrugsIndividualInjection of therapeutic agentInterventionIntervention StudiesLeadMaintenanceMajor Depressive DisorderMeasuresMediator of activation proteinMedicalMental DepressionMental HealthMental disordersMethodsModalityModelingMood DisordersMoodsMotivationOutcomeOutpatientsPatient Self-ReportPatientsPharmaceutical PreparationsProfessional counselorPublic HealthRelapseResearchResourcesRiskRisk BehaviorsSamplingSeveritiesStagingSubstance Use DisorderSubstance abuse problemSymptomsTechniquesTestingTexasTimeTrainingTreatment outcomeValidationVoiceaddictionbasecommunity based treatmentcostdepressive symptomsdesigneffective interventioneffective therapyevidence baseimprovedinnovationmeetingsmethadone maintenancemotivational enhancement therapypleasureprogramspsychosocialtherapy developmenttreatment as usualtreatment strategy
项目摘要
Depression is the most common co-occurring psychiatric disorder in individuals with substance use disorders (SUD). Depression has been associated with both severity of addiction and poor treatment outcome. Previous attempts at treating major depressive disorder (MDD) in individuals with SUD have been hampered by at least one of three limitations: 1) Failure to integrate the treatment of MDD and SUD in one intervention, causing untreated mood symptoms to lead to substance use, while the substance use contributed to the maintenance of mood symptoms; 2) Use of single treatment modalities (e.g., medication alone), also leading to small improvement in most patients; and, 3) Use of complex cognitive interventions requiring highly trained personnel that increase the cost of the interventions and limit their future applicability. The goal of the present application is to start to address this problem.
The focus of this Stage Ia proposal is the development and initial testing of a stepped-care model to provide integrated treatment for SUD and MDD. The intervention, which we preliminarily call Substance Use Comorbidity Care: Evidence-Based Stepped Strategies for Depression (SUCCESS-D) will overcome prior limitations by: 1) Providing integrated treatment of SUD and MDD; 2) Using behavioral and pharmacological interventions; and, 3) Creating an intervention that is counselor-driven to increase feasibility. The combination of provision of integrated treatment and use of complementary treatment approaches should lead to better mood and substance use outcomes, thus addressing a major unsolved need in the treatment of SUD.
The first level of SUCCESS-D, delivered by counselors, will integrate motivational interviewing (MI) and behavioral activation techniques to decrease drug use, promote treatment retention, and reduce depressive symptoms. At the second level, a pharmacological algorithm, the Texas Medication Algorithm for Depression (TMA-D) will be implemented to treat the depressive symptoms of individuals who fail to achieve remission with the first step of SUCCESS-D, while cognitive-behavioral treatment will be offered to those who continue to use substances. It is hoped that this integrated intervention will constitute a more comprehensive and potentially more effective treatment model than currently existing approaches.
Data from this study, which will be conducted in a large methadone maintenance clinic and a large drug-free program, will help plan future intervention studies that will use stepped-care models to provide appropriate treatment strategies for substance abuse patients with other co-occurring disorders or in more diverse community-based treatment settings.
抑郁症是物质使用障碍(SUD)患者中最常见的共同发生的精神障碍。抑郁症与成瘾的严重程度和不良治疗结果有关。以往治疗重度抑郁障碍(MDD)的尝试至少受到以下三个限制之一的阻碍:1)未能将重度抑郁障碍和SUD的治疗整合在一个干预中,导致未经治疗的情绪症状导致物质使用,而物质使用又有助于情绪症状的维持;2)使用单一治疗方式(例如,单独用药),也导致大多数患者的轻微改善;3)使用需要训练有素的人员的复杂认知干预,这增加了干预的成本并限制了其未来的适用性。本应用程序的目标就是开始解决这个问题。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CARLOS BLANCO其他文献
CARLOS BLANCO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CARLOS BLANCO', 18)}}的其他基金
Substance Use Comorbidity Care: Evidence-Based Stepped Strategies for Depression
药物使用合并症护理:基于证据的抑郁症阶梯策略
- 批准号:
7663663 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
2/2 Gambling Addiction: Treatment Mediators and Moderators
2/2 赌博成瘾:治疗中介者和调节者
- 批准号:
7664122 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
2/2 Gambling Addiction: Treatment Mediators and Moderators
2/2 赌博成瘾:治疗中介者和调节者
- 批准号:
7917396 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
Interpersonal therapy for depression in Breast Cancer
乳腺癌抑郁症的人际关系治疗
- 批准号:
7937786 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
Interpersonal therapy for depression in Breast Cancer
乳腺癌抑郁症的人际关系治疗
- 批准号:
8123248 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
Interpersonal therapy for depression in Breast Cancer
乳腺癌抑郁症的人际关系治疗
- 批准号:
8305134 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
2/2 Gambling Addiction: Treatment Mediators and Moderators
2/2 赌博成瘾:治疗中介者和调节者
- 批准号:
8271428 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
2/2 Gambling Addiction: Treatment Mediators and Moderators
2/2 赌博成瘾:治疗中介者和调节者
- 批准号:
8071510 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
Interpersonal therapy for depression in Breast Cancer
乳腺癌抑郁症的人际关系治疗
- 批准号:
7737287 - 财政年份:2009
- 资助金额:
$ 54.41万 - 项目类别:
相似海外基金
StuDy AimED at Increasing AlCohol AbsTinEnce (DEDICATE)
旨在提高酒精戒断率的研究(奉献)
- 批准号:
10577022 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
A Controlled Study of Extended Cannabis Abstinence in Major Depression
重度抑郁症患者长期吸食大麻的对照研究
- 批准号:
478313 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Operating Grants
Exercised-induced modulation of insular cortex microcircuitry during alcohol abstinence
戒酒期间运动诱导的岛叶皮质微电路调节
- 批准号:
10748763 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Prapela™ SVS: A cost-effective stochastic vibrotactile stimulation device toimprove the clinical course of infants with neonatal abstinence syndrome.
Prapela™ SVS:一种经济高效的随机振动触觉刺激装置,可改善患有新生儿戒断综合征的婴儿的临床过程。
- 批准号:
10837421 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Enforced alcohol abstinence: does it reduce reoffending?
强制戒酒:会减少再犯罪吗?
- 批准号:
ES/X003566/1 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Fellowship
Neurobiological impact of acute digital media abstinence among drug using college students
吸毒大学生急性数字媒体戒断的神经生物学影响
- 批准号:
10677380 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Single-cell whole brain imaging of nicotine intoxication, dependence, and abstinence
尼古丁中毒、依赖和戒断的单细胞全脑成像
- 批准号:
10588509 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Understanding recovery from alcohol use disorder: Longitudinal observation of two voluntary temporary abstinence periods
了解酒精使用障碍的恢复:两个自愿临时戒酒期的纵向观察
- 批准号:
10740677 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Sleep Disturbances During Cocaine Abstinence, Dopamine Adaptations, and Motivation for Cocaine
可卡因戒断期间的睡眠障碍、多巴胺适应和可卡因动机
- 批准号:
10681668 - 财政年份:2023
- 资助金额:
$ 54.41万 - 项目类别:
Transcriptional adaptations driving the intensification of alcohol-seeking in dependent rats undergoing prolonged abstinence
转录适应导致长期戒酒的依赖性大鼠对酒精的渴求加剧
- 批准号:
10540014 - 财政年份:2022
- 资助金额:
$ 54.41万 - 项目类别:














{{item.name}}会员




